Skip to main content
. 2022 May 24;13:899221. doi: 10.3389/fpsyt.2022.899221

Table 2.

Change in primary endpoint 1.

Week 2 Week 3 Week 4 Week 6 Week 8 Week 10 Week 12
≥50% reduction in daily joints a 6 (30%) 5 (25%) 8 (40%) 6 (30%) 5 (25%) 4 (20%) 6 (30%)
≤50% reduction in daily joints a 14 (70%) 15 (75%) 12 (60%) 14 (70%) 15 (75%) 16 (80%) 14 (70%)
Total number of patients still followed up 18 15 15 12 11 9 9
Lost to follow-up 2 5 5 8 9 11 11
a

n (%) 1.